Sientra (SIEN) Hits New 1-Year Low at $6.41

Sientra Inc (NASDAQ:SIEN)’s share price hit a new 52-week low during trading on Wednesday . The company traded as low as $6.41 and last traded at $6.49, with a volume of 25474 shares trading hands. The stock had previously closed at $6.70.

SIEN has been the subject of a number of research reports. BidaskClub downgraded Sientra from a “sell” rating to a “strong sell” rating in a report on Wednesday, January 16th. ValuEngine downgraded Sientra from a “strong-buy” rating to a “buy” rating in a report on Thursday, January 24th. William Blair downgraded Sientra from an “outperform” rating to a “market perform” rating in a report on Wednesday, March 13th. Maxim Group reiterated a “buy” rating and issued a $20.00 price objective on shares of Sientra in a report on Monday, February 11th. Finally, Craig Hallum set a $23.00 price objective on Sientra and gave the stock a “buy” rating in a report on Tuesday, March 26th. One investment analyst has rated the stock with a sell rating, four have given a hold rating and six have assigned a buy rating to the stock. Sientra has an average rating of “Hold” and an average price target of $21.00.

The company has a debt-to-equity ratio of 0.58, a current ratio of 1.52 and a quick ratio of 1.16. The firm has a market cap of $195.77 million, a price-to-earnings ratio of -2.00 and a beta of -0.10.



Sientra (NASDAQ:SIEN) last issued its quarterly earnings results on Wednesday, May 8th. The medical instruments supplier reported ($0.91) earnings per share for the quarter, missing the consensus estimate of ($0.76) by ($0.15). Sientra had a negative net margin of 126.32% and a negative return on equity of 119.59%. The company had revenue of $17.55 million for the quarter, compared to the consensus estimate of $17.00 million. As a group, equities analysts forecast that Sientra Inc will post -2.95 EPS for the current fiscal year.

Several large investors have recently modified their holdings of SIEN. Goldman Sachs Group Inc. raised its position in shares of Sientra by 667.8% in the 1st quarter. Goldman Sachs Group Inc. now owns 483,176 shares of the medical instruments supplier’s stock worth $4,146,000 after acquiring an additional 420,244 shares in the last quarter. Jefferies Group LLC bought a new position in shares of Sientra in the 1st quarter worth $105,000. Geode Capital Management LLC raised its position in shares of Sientra by 11.9% in the 1st quarter. Geode Capital Management LLC now owns 285,056 shares of the medical instruments supplier’s stock worth $2,445,000 after acquiring an additional 30,309 shares in the last quarter. Charles Schwab Investment Management Inc. raised its position in shares of Sientra by 7.1% in the 1st quarter. Charles Schwab Investment Management Inc. now owns 54,682 shares of the medical instruments supplier’s stock worth $470,000 after acquiring an additional 3,616 shares in the last quarter. Finally, Formula Growth Ltd. raised its position in shares of Sientra by 9.1% in the 1st quarter. Formula Growth Ltd. now owns 120,000 shares of the medical instruments supplier’s stock worth $1,030,000 after acquiring an additional 10,000 shares in the last quarter. Hedge funds and other institutional investors own 86.18% of the company’s stock.

COPYRIGHT VIOLATION WARNING: This story was originally published by Dakota Financial News and is the property of of Dakota Financial News. If you are reading this story on another publication, it was stolen and republished in violation of U.S. and international copyright & trademark laws. The correct version of this story can be read at https://dakotafinancialnews.com/2019/05/15/sientra-sien-hits-new-1-year-low-at-6-41.html.

Sientra Company Profile (NASDAQ:SIEN)

Sientra, Inc, a medical aesthetics company, develops and sells medical aesthetics products to plastic surgeons in the United States. It operates through two segments, Breast Products and miraDry. The company offers silicone gel breast implants for use in breast augmentation and breast reconstruction procedures; breast tissue expanders; and scar management products under the Sientra, AlloX2, Dermaspan, Softspan, and BIOCORNEUM brand names.

Featured Article: How do buyers and sellers choose a strike price?

Receive News & Ratings for Sientra Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sientra and related companies with MarketBeat.com's FREE daily email newsletter.